Journal of the European Academy of Dermatology and Venereology

Article	Citations
Comparison of performance of SCORTEN, ABCD‐10 and Re‐SCORTEN in a cohort of patients with Stevens–Johnson syndrome/toxic epidermal necrolysis	222
Papillon‐Lefevre syndrome treated by acitretin: case report and cytokine profile	156
Ichthyotic skin lesions of Conradi–Hünermann–Happle syndrome successfully treated with dupilumab	145
Age matters: Rethinking SLNB's reliability in melanoma mortality prediction	140
The European quest to reduce health risks associated with indoor tanning	125
Announcement	124
Aquagenic pruritus: A web‐based survey study exploring itch characteristics, therapeutic options and patient perspectives	122
Successful treatment with tralokinumab in patients with atopic dermatitis and dupilumab‐induced psoriasis	106
Electrochemotherapy with bleomycin for basal cell carcinomas: a systematic review	98
Foreword	91
Harlequin syndrome	88
Clinical and trichoscopic aspects of scalp psoriasis: commentary to ‘Clinical and trichoscopic features in various forms of scalp psoriasis’ by F. Bruni et al.	76
Announcement	75
Associations between clinical variables and treatment regimens and hair density and calibre in female androgenetic alopecia patients: a retrospective study of 602 patients	70
Evaluating for audiological differences in children with alopecia areata	66
Use of SEM/EDX methods for the analysis of ambient particulate matter adhering to the skin surface	63
High prevalence of extracutaneous involvement in ITG junctional epidermolysis bullosa	62
Two cases of cerebrovascular accidents following the induction dose of risankizumab	59
Reply to ‘Burnout and professional quality of life in dermatologists’	59
Acute urticaria management: Gaps, challenges and the need for further evidence	58
Chronic nodular prurigo: Association between comorbidities, itch and quality of life	58
Efficacy and safety of JAK inhibitors in treating lichen planopilaris or frontal fibrosing alopecia	58
Mepolizumab therapy for eosinophilic pustular folliculitis (Ofuji disease)	57
Novel variant in WNT10A caused short anagen hair syndrome in a Chinese pedigree	56
The impact of hand eczema	54

Difficulties in diagnosing dermatophytomas: Analysis of clinical and dermoscopic findings	54
Announcement	53
The challenge of palmoplantar pustulosis therapy: Are Interleukin‐23 inhibitors an option?	49
Fibrillar pattern as ultrasonographic progression biomarker of hidradenitis suppurativa	49
Regulating sunbed use: Skin cancer risks linked to tanning beds	49
Cryoinflation as an alternative treatment for fistulas in hidradenitis suppurativa	49
Rosacea and upper gastrointestinal disorders: a case‐control study from a large, urban academic centre	48
Predictors of malignancy in melanocytic lesions presenting as new lesions compared to baseline total body photography: A case–control study	47
Use of therapeutic patient education tools for atopic dermatitis: A French national survey	45
Efficacy of long‐term risankizumab treatment for moderate‐to‐severe plaque psoriasis: Subgroup analyses by baseline characteristics and psoriatic disease manifestations through 256 weeks (LIMMitl	44
Assessment of the protective effect against air pollution‐induced skin pigmentation of an oral nutritional supplement containing antioxidants: A randomized, double‐blinded, placebo‐controlled study	44
Psoriasis may increase the risk of lung cancer: a two‐sample Mendelian randomization study	44
Multiple myeloma, haematologic malignancy and immunosuppressant and immunomodulatory medications are associated with sebaceous carcinoma, a pharmacovigilance study of the FDA adverse event	43
The risk of ultraviolet exposure for melanoma in Fitzpatrick skin types I–IV: A 20‐year systematic review with meta‐analysis for sunburns	42
Pioneers in Dermatology and Venereology: An Interview with Professor Alain Taieb	41
Effectiveness and safety of tildrakizumab for the treatment of psoriasis in real‐world settings at 24 weeks: A retrospective, observational, multicentre study by the Spanish Psoriasis Group	41
Issue Information	41
Seroconversion and neutralizing antibodies production after completion of Pfizer‐BioNTech BNT 162b2 vaccination scheme among psoriatic patients receiving biological or topical treatment: A	41
Pigtail hairs in syphilitic alopecia	41
Long‐term, durable, absolute Psoriasis Area and Severity Index and health‐related quality of life improvements with risankizumab treatment: a post hoc integrated analysis of patients with moder	40
Announcement	40
Single‐cell transcriptomic analysis of GPP patients treated with IL‐12/23 or IL‐17A blockade	40
Announcement	40
Automated dermatoscopic pattern discovery by clustering neural network output for human–computer interaction	39
Socioeconomic status, biologics and all‐cause mortality	39
Commentary on vitiligo patient population and disease burden in France: VIOLIN Study results from the CONSTANCES cohort	39
	38
Randomized Phase 3 trial demonstrating high efficacy, favourable safety and convenience of a novel calcipotriol and betamethasone dipropionate cream for the treatment of psoriasis	38
A new era for alopecia areata: New treatments and improved knowledge of the condition	37
Issue Information	37
The chicken or the egg of lymphopenia in atopic eczema	37
Announcement	36
Announcement	36
Announcement	36
	35
Long‐term patient‐reported perception and experience of methylprednisolone pulse with or without methotrexate in alopecia areata: A French retrospective single‐centre cohort	34
Successful therapy of pemphigoid gestationis with dupilumab—A new case	34
Probable chromoblastomycosis following bee sting: An unusual presentation	34
Paradoxical lichen planus induced during anti‐IL‐17A treatment is immunologically different from spontaneously occurring lichen planus	34
Safe administration of subsequent mRNA COVID‐19 vaccine doses following a possible allergic reaction to the first dose	34
Announcement	34
Lingua villosa nigra in a child after COVID: Review and differential diagnosis with oral pigmentations of childhood	33
Cole disease due to a novel pathogenic variant in the ENPP1 gene	33
The direct impact of the national skin cancer awareness month campaign on melanoma diagnosis in Greece	32
What makes dermatological images go viral? A social media analysis	32
Angiolymphoid hyperplasia with eosinophilia infiltrated by GATA3+ Th2 cells responding to dupilumab	32
	31
Dupilumab use for atopic dermatitis during pregnancy: A systematic review	30
Acceptance rate of genital dermatologic examination during routine consultation and the reasons for refusal: A cross‐sectional study	30
Towards a more comprehensive evaluation: Addressing limitations in the study of dupilumab and pregnancy outcomes	30

Successful response of upadacitinib in different clinical phenotypes of atopic dermatitis	30
Increased sodium consumption is associated with psoriasis: A population‐based cohort study	30
The role of genetic factors and peripheral immune cells in SAPHO syndrome	29
Creation and evaluation of an online dermoscopy test for self‐evaluation of competences in diagnosis of skin cancer	29
A study of corticophobia in adult psoriasis patients: a French cross‐sectional observational study	29
Changes in the incidence of contagious infectious skin diseases after the COVID‐19 outbreak	29
Announcement	29
Mucocutaneous leishmaniasis complicating systemic lupus erythematosus and responding to high dose amphotericin B	29
Individual meta‐analysis of vital prognostic factors of patients with bullous pemphigoid	29
Quincke, quincke‐like and pseudo‐quincke signs: nosology of cutaneous phenomena	29
Sexually transmitted infections epidemiology and risk assessment at the main correctional facility in Malta (2017–2019)	29
Pioneers in Dermatology and Venereology: An Interview with Professor Danilo V. Stevanovic	29
Skincare influencers and skin problems in social media	29
Editor’s Picks	29
Announcement	28
Announcement	28
Prognostic factors for treatment failure of imiquimod treatment in basal cell carcinoma – an observational study	28
Exacerbation of acrodermatitis chronica atrophicans under antiretroviral treatment in an HIV‐infected patient	28
Issue Information	28
Cavitary pulmonary tuberculosis during treatment with guselkumab	28
Evaluating the potential cost savings from inpatient dermatology consultations	28
Scabies in monasteries in Phnom Penh, Cambodia	28
Application of integrated skincare in medical aesthetics: A literature review	27
Influence of perioperative antiplatelet and anticoagulant medication management on bleeding events in dermatosurgery—A prospective observational study	27
Severe skin eruption with features of drug reaction with eosinophilia and systemic symptoms (DRESS) during vemurafenib treatment of melanoma	27
A new in vitro method to predict in vivo photoprotection of skin hyperpigmentation induced by visible light	27
Development of eruptive pseudoangiomatosis following immunization with COVISHIELD vaccine in an adult	27
Tralokinumab efficacy in a case of dupilumab‐resistant severe atopic dermatitis complicated by eczema herpeticum	27
A case of eruptive halo nevi following COVID‐19	27
Penile ischaemia secondary to COVID‐19: why should the dermatologist be concerned?	26
Pharmacological interventions for periorificial (perioral) dermatitis in children and adults: a systematic review	26
Clinically uninvolved but not healthy—The skin of patients with atopic dermatitis is primed for itch and inflammation	26
Efficacy of imiquimod in the management of lentigo maligna	26
Line‐field confocal optical coherence tomography of Darier's disease: A case series with histopathological correlation	26
Course and outcome of chilblain‐like acral lesions during COVID‐19 pandemic	26
Pharmacovigilance: The responsibility of all	25
Dermoscopic spectrum of mycosis fungoides: a retrospective observational study by the International Dermoscopy Society	25
Genomic and antimicrobial resistance analyses of Neisseria gonorrhoeae isolates, Burkina Faso, 2018–2019	25
New onset pemphigus foliaceus following AstraZeneca COVID‐19 vaccination	25
	25
Epidermolysis bullosa pruriginosa with extensive truncal involvement treated with upadacitinib	25
Artificial intelligence—ChatGPT and Scientific Publishing	25
	25
The use of pegylated interferon a‐2a in a cohort of Greek patients with mycosis fungoides	25
Solar elastosis and melanoma‐specific survival: A systematic review and meta‐analysis	24
Proposed management algorithm for dupilumab‐associated ocular side effects: a collaborative effort between dermatologists and ophthalmologists	24
Pfizer/BioNTech‐associated perniosis in two young adults with re‐challenge evidence	24
JEADV Clinical Practice: the new Open Access journal of the EADV	24
Lymphocyte subsets and Langerhans cells in the skin of kidney transplant recipients under three different immunosuppressive regimens	24
Issue Information	24
Response to ‘A skin reaction with rust‐like discolouration to mRNA COVID‐19 vaccine’	24
Editors Picks May 2023	24
Extensive furuncular myiasis in a travel returnee from Africa	24
	24
Announcement	23
Pioneers in Dermatology and Venereology: an interview with Professor Sarolta Kárpáti	23
Response to comment by Thompson on ‘Position Statement on the Role of Nurses in Therapeutic Patient Education in Atopic Dermatitis’	23
Editor's Picks	23
Epithelioid cell granuloma formation in CARD14‐associated papulosquamous eruptions	23
	23
Clinical evaluation of anaesthetic‐like effect of two dermocosmetic formulations containing Aquaphilus dolomiae extract‐G3 in subjects with sensitive facial skin	23
Issue Information	23
Unmet needs in bullous pemphigoid: definition of accurate and combined diagnostic criteria	23
Poor correlation between diameter and Breslow thickness of melanoma	22
Palmoplantar pustulosis and acrodermatitis continua of Hallopeau: demographic and clinical comparative study in a large multicentre cohort	22
Pioneers in Dermatology and Venereology: an Interview with Professor David M. Pariser	22
Unveiling melanomagenesis through the dermatoscope	22
Atopic dermatitis and cancer risk—New insights from mendelian randomization?	22
Impact of xerosis cutis, with or without skin disease, on health‐related quality of life: A prospective study	22
Announcement	22
Culture‐free genotyping of Neisseria gonorrhoeae from urogenital samples in a high‐density urban area in the North of Italy	22
Altered brain activity and cognitive impairment in patients with psoriasis	22
A comprehensive review of nondermatophyte mould onychomycosis: Epidemiology, diagnosis and management	22
Drug survival, effectiveness and safety of ixekizumab for moderate‐to‐severe psoriasis up to 5 years	22
Myriad of pigmented lesions in a patient with Costello syndrome	22
Editor's picks	21
Flat scalp melanoma dermoscopic and reflectance confocal microscopy features correspond to histopathologic type and lesion location	21
A dermocosmetic product containing the sap of oat plantlets and Garcinia mangostana extract improves the clinical signs of acne	21
Announcement	21
The significance of exanthems in COVID‐19 patients hospitalized at a tertiary care centre	21

	21
Pioneers in Dermatology and Venereology: an interview with Professor Ricardo Luis Galimberti	21
Announcement	21
Long‐term efficacy (up to 68 weeks) of Baricitinib in combination with topical corticosteroids in adult patients with moderate‐to‐severe atopic dermatitis: Analysis of treatment responders, partial re	21
Reply to ‘Impact of the French COVID‐19 pandemic lockdown on newly diagnosed melanoma delay and severity’ by R. Molinier et al.	20
Androgenetic alopecia in women and men is not related to COVID‐19 infection severity: a prospective cohort study of hospitalized COVID‐19 patients	20
Stevens–Johnson syndrome induced by tonic water	20
Alexithymia and dissociation in psychogenic pruritus: Clinical relevance and therapeutic implications	20
Effect of weekly vitamin D supplementation on the severity of atopic dermatitis and type 2 immunity biomarkers in children: A randomized controlled trial	20
Brachioradial pruritus successfully treated with intravenous naloxone	20
Increased expression of β2‐adrenoceptors is involved in vitiligo‐associated grey hair	20
Dermatological manifestations in Costello syndrome: A prospective multicentric study of 31 HRAS‐positive variant patients	20
Erythema punctatum Higuchi: reconsidering its relationship with adrenergic urticaria and eruptive pseudoangiomatosis	20
French data on the epidemiology and expert healthcare network for epidermolysis bullosa	20
Polymorphisms in corticotrophin‐releasing hormone–proopiomalanocortin (CRH–POMC) system genes: Neuroimmune contributions to psoriasis disease	20
	20
Polygenic risk score as a determinant of risk of keratinocyte cancer in an Australian population‐based cohort	20
A topical emollient mitigates the progression of cognitive impairment in the elderly: a randomized, open‐label pilot trial	20
Fluorescence advanced videodermoscopy: a new method of hairs and scalp evaluation. Comparison with trichoscopy.	20
LC‐MS/MS and immuno‐electron subtyping combined with genetics show that OSMR mutations cause amyloid deposition of keratins 5/14 in familial primary localized cutaneous amyloidosis	20
Announcement	20
Single‐cell RNA‐seq reveals abnormal differentiation of keratinocytes and increased inflammatory differentiated keratinocytes in atopic dermatitis	20
Trend of sexually transmitted infections during the Covid‐19 age. What was the impact of the pandemic and the social distancing measures?	20
Juvenile localized scleroderma: A single‐centre experience from India	19
Prevalence and predictors of perceived stigmatization in adult patients with moderate‐to‐severe atopic dermatitis in France	19
Minoxidil and vitamin E therapy for nail growth disorders: A retrospective study	19
Causes of longitudinal nail splitting: a retrospective 56‐case series with clinical pathological correlation	19
Efficacy of ixekizumab on nail psoriasis in paediatric patients with moderate‐to‐severe psoriasis: a post hoc analysis from IXORA‐PEDS	19
Announcement	19
Comparison of molecular and serological assays on cerebrospinal fluid for the diagnosis of neurosyphilis	19
Keratoacanthoma or cutaneous squamous cell carcinoma revealing a DNA mismatch repair default (Muir‐Torre Syndrome)	19
Association of atopic dermatitis with new‐onset migraine: A nationwide population‐based cohort study	19
The transition from mild to moderate‐to‐severe chronic plaque psoriasis	19
Ethics in the Dermoverse: The challenge of a new technological era comment on ‘Are non‐fungible tokens the barrier to realizing the Dermoverse?’	19
‘Gothic’ naritis—Recurrent unilateral traumatic fissured angular naritis complicated by intermittent ipsilateral nasal tip erysipelas	18
2013–2023: A decade of progress and challenges in dermatology as reflected in JEADV	18
Effectiveness of secukinumab for the treatment of erythrodermic psoriasis: Multicentre study in daily practice	18
Validation of dermatopathological criteria to diagnose cutaneous lesions of mastocytosis: importance of KIT D816V mutation analysis	18
Progress in Dermatology and Venereology in 2023 as reflected in the Journal of the European Academy of Dermatology and Venereology	18
Unsatisfactory agreement using current classification of maculopapular cutaneous mastocytosis	18
Intriguing concept of pigmented contact dermatitis: Further understanding the role of hair colours including natural henna	18
Giant rapidly involuting congenital haemangioma and Kasabach‐Merritt phenomenon: A potentially underhanded trap	18
	18
Dermoscopy of mudi‐chood disease (hair‐heat disease): A traditional hair grooming related dermatoses in South Indian women	18
Dengue: Another viral infection with mucocutaneous manifestations	18
Resilience of patients with skin diseases in France: A cross‐sectional study	18
Editor's Picks December 2023	18
Dispositional optimism and resilience in patients with psoriasis in France: A cross‐sectional study	18
Mechanism of action of chlormethine gel in mycosis fungoides	18
Baseline knowledge of dermatology specialists/residents on hidradenitis suppurativa and immediate learning outcome after their participation at an EADV School	18
Editor's Picks January 2024	18
Announcement	17
Impact of menopause on the skin…information still insufficient	17
Koebner phenomenon with lichen planus in an area of previous vitiligo after COVID‐19 vaccination and the creation of a locus minoris resistentiae	17
Cutaneous body image in patients with rosacea: A cross‐sectional study	17
Phototherapy for atopic dermatitis: Is the light still shining?	17
Exacerbation of acquired perforating dermatosis following SARS‐CoV‐2 vaccination	17
Skin adverse reactions to Sars‐CoV‐2 vaccination: a relevant responsibility issue for dermatologists	17
COVID‐19 vaccine side effects in patients with and without atopic dermatitis	17
Dermoscopy of annular lichenoid dermatitis of youth (ALDY): An observational controlled study	17
Characterization of non‐responders to interleukin‐17 inhibitors in moderate to severe psoriasis patients enrolled in the Corrona® Psoriasis Registry	17
Immunogenicity and safety of anti‐SARS‐CoV‐2 BNT162b2 vaccine in psoriasis patients treated with biologic drugs	17
Dermatology textbooks in Scandinavia should prepare medical students for ethnic diversity	17
SARS‐CoV‐2 mRNA booster vaccine‐associated lichenoid drug eruption	17
Treatment of primary axillary hyperhidrosis with a cream formulation of oxybutynin chloride 10%	17
Acrodermatitis chronica atrophicans with clonal light chains and heavy chain rearrangement	17
Novel ADAR1 mutations in three cases of psoriasis coexisting with dyschromatosis symmetrica hereditaria	17
A case of hidradenitis suppurativa in a 19th‐century painting at the Leopold Museum?	17
A Bullous Eruption following the Pfizer‐BioNTech COVID‐19 vaccination	17
Announcement	17
Late‐onset Adamantiades–Behçet's disease—systematic review and meta‐analysis	17
Erythema multiforme major associated with molnupiravir treatment for SARS‐CoV‐2 infection: First report	17
Scar diastasis index: a smart and reproducible tool to evaluate long‐standing scars	17
Do psoriasis and atopic dermatitis affect erectile dysfunction? Insights from a Mendelian randomization study	17
Hair flag sign: Macroscopic and trichoscopic feature of hair regrowth in alopecia areata	16
Efficacy of low‐dose methotrexate in a short‐regimen for granulomatous sarcoid‐like reaction on permanent make‐up during COVID‐19 infection	16
A case of acrocyanosis in a painting of the 17th century	16
Development of thoracic sarcoid reactions associated with complete response to anti‐PD‐1 therapy in a patient with advanced cutaneous squamous cell carcinoma	16
Angiotensin‐converting enzyme 2 expression is elevated in tissue of hidradenitis suppurativa and pyoderma gangrenousm and demonstrates a different pattern of expression to psoriasis vulgaris	16
Neurofibromatosis type 1: Factors associated with flare‐ups of cutaneous neurofibromas at puberty	16
Issue Information	16
Editor's Picks	16
Editor's Picks	16
The changing landscape of managing hair loss: a 30‐year perspective	16
Pioneers in Dermatology and Venereology: An Interview with Professor An Goossens	16
Fortuitous discoveries in dermatology	16
Issue Information	16
Reply to ‘A rare case of adrenergic urticaria in a child’ by Schnebert et al.	16
Pruritus and prurigo: a significant advancement on diagnosis, classification, pathogenesis and treatment	16
Comment on ‘Negative SARS‐CoV‐2 antibodies in patients with positive immunohistochemistry for spike protein in pityriasis rosea‐like eruptions’	16
Multiple basal cell carcinomas revealing a biallelic MUTYH gene mutation in a 39‐year‐old male patient	16
Complication rate of wide local excision in patients with pT1a melanoma	16
Dermoscopy of nodular scabies: An observational study	16
Severe atopic dermatitis in a patient with Loeys‐Dietz syndrome treated with dupilumab	16
ApreScalp: A Phase 4 multicentre, randomized, placebo‐controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate‐to‐severe scalp psoriasi	16